Dr. Ricardo Correa Marquez, M.D
NPI: 1053623538
Total Payments
$82,812
2024 Payments
$52,541
Companies
18
Transactions
68
Medicare Patients
59
Medicare Billing
$6,003
Payment Breakdown by Category
Research$38,192 (46.1%)
Consulting$22,190 (26.8%)
Other$12,274 (14.8%)
Travel$7,206 (8.7%)
Food & Beverage$2,949 (3.6%)
Education$0.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,192 | 1 | 46.1% |
| Consulting Fee | $22,190 | 7 | 26.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,849 | 4 | 11.9% |
| Travel and Lodging | $7,206 | 15 | 8.7% |
| Food and Beverage | $2,949 | 39 | 3.6% |
| Honoraria | $2,425 | 1 | 2.9% |
| Education | $0.35 | 1 | 0.0% |
Payments by Type
General
$44,619
67 transactions
Research
$38,192
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | $38,192 | 1 | $0 (2024) |
| Novo Nordisk Inc | $12,888 | 9 | $0 (2024) |
| Ascendis Pharma Inc | $6,754 | 9 | $0 (2023) |
| Corcept Therapeutics | $6,222 | 14 | $0 (2023) |
| ModernaTX, Inc. | $6,119 | 4 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $4,214 | 9 | $0 (2023) |
| Chiesi USA, Inc. | $2,609 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $2,170 | 2 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $1,665 | 1 | $0 (2022) |
| PFIZER INC. | $1,250 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,541 | 9 | RECORDATI_RARE_DISEASES_INC. ($38,192) |
| 2023 | $17,702 | 25 | Ascendis Pharma Inc ($6,754) |
| 2022 | $5,677 | 6 | Nestle HealthCare Nutrition Inc. ($2,957) |
| 2021 | $626.13 | 4 | Nestle HealthCare Nutrition Inc. ($325.59) |
| 2020 | $5,821 | 12 | Corcept Therapeutics ($5,783) |
| 2019 | $224.04 | 6 | Corcept Therapeutics ($125.00) |
| 2018 | $220.42 | 6 | Novo Nordisk Inc ($137.20) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $169.87 | General |
| 12/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | — | Cash or cash equivalent | $38,192.30 | Research |
| Study: Ricardo Correa at Cleveland Clinic on Detecting Mild Autonomous Cortisol Secretion in Patients with Adrenal Incidentaloma • Category: ENDOCRINE AGENT | ||||||
| 06/20/2024 | Chiesi USA, Inc. | — | Honoraria | Cash or cash equivalent | $2,425.00 | General |
| 06/20/2024 | Chiesi USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $53.28 | General |
| 05/10/2024 | Chiesi USA, Inc. | MYALEPT (Drug) | Food and Beverage | Cash or cash equivalent | $130.44 | General |
| Category: GENERALIZED LIPODYSTROPHY | ||||||
| 01/19/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 01/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $380.15 | General |
| 01/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $314.77 | General |
| 01/03/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 12/21/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/21/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/09/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Travel and Lodging | In-kind items and services | $701.59 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/09/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Food and Beverage | In-kind items and services | $144.97 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/27/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $100.63 | General |
| Category: Endocrinology | ||||||
| 10/26/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $67.20 | General |
| Category: Endocrinology | ||||||
| 10/01/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 06/15/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $110.72 | General |
| Category: TEPEZZA | ||||||
| 06/01/2023 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,184.00 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Travel and Lodging | Cash or cash equivalent | $491.80 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Travel and Lodging | Cash or cash equivalent | $354.17 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Travel and Lodging | Cash or cash equivalent | $313.89 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $175.00 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 05/20/2023 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $60.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Ricardo Correa at Cleveland Clinic on Detecting Mild Autonomous Cortisol Secretion in Patients with Adrenal Incidentaloma | RECORDATI_RARE_DISEASES_INC. | $38,192 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 59 | 59 | $41,005 | $6,003 |
Total Patients
59
Total Services
59
Medicare Billing
$6,003
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $20,690 | $3,374 | 16.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 20 | $11,735 | $2,116 | 18.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2023 | 13 | 13 | $8,580 | $512.28 | 6.0% |
About Dr. Ricardo Correa Marquez, M.D
Dr. Ricardo Correa Marquez, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in East Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1053623538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ricardo Correa Marquez, M.D has received a total of $82,812 in payments from pharmaceutical and medical device companies, with $52,541 received in 2024. These payments were reported across 68 transactions from 18 companies. The most common payment nature is "" ($38,192).
As a Medicare-enrolled provider, Correa Marquez has provided services to 59 Medicare beneficiaries, totaling 59 services with total Medicare billing of $6,003. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location East Providence, RI
- Active Since 07/13/2010
- Last Updated 03/16/2016
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1053623538
Products in Payments
- ISTURISA (Drug) $38,192
- Korlym (Drug) $6,222
- Moderna Covid-19 Vaccine (Biological) $6,119
- JARDIANCE (Drug) $1,677
- PREVNAR 20 (Biological) $875.00
- TEPEZZA (Drug) $231.48
- Proclaim IPG (Device) $209.09
- MYALEPT (Drug) $130.44
- Victoza (Drug) $103.14
- XARELTO (Drug) $91.45
- INVOKANA (Drug) $55.47
- Minimed 670G System (Device) $53.28
- Ozempic (Drug) $35.68
- PROCLAIM (Device) $33.75
- NATPARA (PARATHYROID HORMONE) (Drug) $25.31
- NATPARA (Drug) $18.11
- Saxenda (Drug) $16.64
- (820) Cholbam (Drug) $0.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.